J. Lipid Res.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1194/jlr.M400306-JLR200 on October 16, 2004

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
M400306-JLR200v1
46/1/115    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Asatryan, L.
Right arrow Articles by Sevanian, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Asatryan, L.
Right arrow Articles by Sevanian, A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Journal of Lipid Research, Vol. 46, 115-122, January 2005
Copyright © 2005 by American Society for Biochemistry and Molecular Biology

LDL phospholipid hydrolysis produces modified electronegative particles with an unfolded apoB-100 protein

Liana Asatryan1,*, Ryan T. Hamilton*, J. Mario Isas{dagger}, Juliana Hwang*, Rakez Kayed§ and Alex Sevanian*

* Department of Molecular Pharmacology and Toxicology, School of Pharmacy, University of Southern California, Los Angeles, CA 90033
{dagger} Department of Biochemistry and Molecular Biology, Keck School of Medicine, Zilkha Neurogenetic Institute, and Arnold and Mabel Beckman Macular Research Center, University of Southern California, Los Angeles, CA 90033
§ Department of Molecular Biology and Biochemistry, University of California, Irvine, CA 92697

1 To whom correspondence should be addressed. e-mail: asatryan{at}usc.edu

Electronegative low density lipoprotein (LDL) formation that structurally resembles LDL isolated from plasma was evaluated after LDL treatment with snake venom phospholipase A2 (PLA2). PLA2 treatment of LDL increased its electrophoretic mobility in proportion to the amount of LDL formed without evidence of lipid peroxidation. These changes dose-dependently correlated with the degree of phospholipid hydrolysis. Strong immunoreactivity of LDL subfraction from plasma and PLA2-treated LDL (PLA2-LDL) to amyloid oligomer-specific antibody was observed. Higher ß-strand structural content and unfolding proportionate to the loss of {alpha}-helical structure of apolipoprotein B-100 (apoB-100) of LDL isolated from both native and PLA2-LDLs was demonstrated by circular dichroism (CD) spectropolarimetry. These structural changes resembled the characteristics of some oxidatively modified LDLs and soluble oligomeric aggregates of amyloidogenic proteins. PLA2-LDL was also more susceptible to nitration by peroxynitrite, likely because of exposure of otherwise inaccessible hydrophilic and hydrophobic domains arising from apoB-100 unfolding. This was also demonstrated for plasma LDL. In contrast, PLA2-LDL was more resistant to copper-mediated oxidation that was reversed upon the addition of small amounts of unsaturated fatty acids.

The observed similarities between PLA2-LDL-derived LDL and plasma LDL implicate a role for secretory PLA2 in producing modified LDL that is facilitated by unfolding of apoB-100.

Abbreviations: Aß, amyloid ß; apoB-100, apolipoprotein B-100; CD, circular dichroism; LDL, electronegative low density lipoprotein; MDA, malondialdehyde; nLDL, normal LDL subfraction devoid of LDL; REM, relative electrophoretic mobility; sPLA2, secretory phospholipase A2; tLDL, total LDL

Supplementary key words apolipoprotein B-100 • atherogenic low density lipoprotein • lipid peroxidation • oxidation • nitrotyrosine • unsaturated fatty acids • ß-strand structures • protein structure • secretory phospholipase A2


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
L. Ai, M. Rouhanizadeh, J. C. Wu, W. Takabe, H. Yu, M. Alavi, R. Li, Y. Chu, J. Miller, D. D. Heistad, et al.
Shear stress influences spatial variations in vascular Mn-SOD expression: implication for LDL nitration
Am J Physiol Cell Physiol, June 1, 2008; 294(6): C1576 - C1585.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. Lu, W. Jiang, J.-H. Yang, P.-Y. Chang, J. P. Walterscheid, H.-H. Chen, M. Marcelli, D. Tang, Y.-T. Lee, W. S.L. Liao, et al.
Electronegative LDL Impairs Vascular Endothelial Cell Integrity in Diabetes by Disrupting Fibroblast Growth Factor 2 (FGF2) Autoregulation
Diabetes, January 1, 2008; 57(1): 158 - 166.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Sneck, P. T. Kovanen, and K. Oorni
Decrease in pH Strongly Enhances Binding of Native, Proteolyzed, Lipolyzed, and Oxidized Low Density Lipoprotein Particles to Human Aortic Proteoglycans
J. Biol. Chem., November 11, 2005; 280(45): 37449 - 37454.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.